# Remote Monitored Systems appoints Dr Gareth Cave and Dr Felicity Sartain as non-executive directors

- Link: https://www.directorstalkinterviews.com/remote-monitored-systems-appoints-dr-gareth-cave-and-dr-felicity-sartain-as-non-executive-directors/412978923
- Published: 2021-04-19T07:15:55+01:00
- Author: Giles

Further to the announcement of 18 February 2021, **Remote Monitored Systems plc**(
[LON:RMS](https://www.directorstalkinterviews.com/company/remote-monitored-systems-plc/rms.l))
has announced the appointments of Dr Gareth Cave and Dr Felicity Sartain as non-
executive directors of the Company, effective immediately. Dr Felicity Sartain will
be an independent non-executive director.  

Dr Gareth Cave is a founder and Chairman of Pharm2Farm Ltd, the Company’s wholly
owned subsidiary. Dr Cave gained his BSc, MSc and PhD in Chemistry from the University
of Warwick. He subsequently co-established the Australian Centre for Green Chemistry
at Monash University in Australia, whilst also pioneering a new “green” solvent-
free chemical reaction process, that later led to the two patents licenced to P2F
to manufacture and fictionalise their nanotechnology processes. Dr Cave later went
on to work as an academic at the Universities of Leeds, Liverpool and University
of Missouri, USA before returning to the UK at Nottingham Trent University in 2005
where he is currently Head of Inorganic Chemistry. His current interdisciplinary
university research group, of 11 PhD’s utilise nanotechnology across a plethora 
of applications from cancer immunology, and treatments of Alzheimer’s through to
food security – both plant and livestock.

Dr Felicity Sartain has a multi-disciplinary background established over 10 years
including managerial, commercial and research in the Healthcare, Life Science and
Nanotechnology sectors. She holds a PhD in Biotechnology from the University of 
Cambridge and an MSc in Chemistry at the University of York. She has also undertaken
Post-Doctoral Research at the University of Cambridge following an industrial placement
with [GlaxoSmithKline](https://www.directorstalkinterviews.com/ftse-company/glaxosmithkline-plc/gsk.l).
Felicity is currently Chief Operating Officer of Closed Loop Medicine where she 
initially worked as a consultant from September 2017.

> **Antony Legge, Executive Chairman of Remote Monitored Systems, said:**
> “We are delighted to welcome both Gareth and Felicity to the Board.  They are 
> both highly accomplished in their fields with deep knowledge and experience in
> nanotechnology. The appointments strengthen and extend the Board’s skill set, 
> and we very much look forward to benefitting over the coming years as their contributions
> support RMS’s growth trajectory.” 

Share on:
